Click to watch the Pre-webinar interview
Revised guidelines for the diagnosis and management of thyroid disease in pregnancy and post-partum are due to be released soon. Preliminary information on the new guidelines suggest they update the 2017 guidelines on the issue of reference ranges for pregnant women for TSH and fT4. The 2025 guidelines will likely suggest that laboratory- and trimester-specific reference intervals for TSH and fT4 are the preferred standard for use during pregnancy. In the absence of laboratory- and trimester-specific TSH reference intervals, it would be reasonable to use a fixed TSH reference interval of 0.1-4.0 mU/L during the first and second trimesters. This is based on expert opinion and an extrapolation of average values from reference interval studies. This new guidance should reduce the diagnosis of mild disease and increase the relative number of cases of overt hypothyroidism and hypothyroxinemia identified [Korevaar TIM, Nov 2024. MedEA Thyroid Disorders Webinar Presentation]. The revised guidelines have also updated several characteristics that would have previously merited thyroid disorder screening [Korevaar TIM, Nov 2024. MedEA Thyroid Disorders Webinar Presentation]. The changes to the guidelines will be highlighted during this webinar to help update clinicians and ensure they are working to current best practice.
At the end of this activity, learners should be able to:
Endocrinologists and other healthcare professionals involved in the diagnosis and management of thyroid disorders. All materials will be suitable for all geographic regions.
English with simultaneous translation into Spanish and Chinese
CME Live Webinar
Hypothyroidism in pregnancy: New guidelines
13.00 – 13.05 Webinar opening, introductions and aims
Nemencio A Nicodemus Jr, Philippines
13.05 – 13.25 Overview of the 2025 ATA Guidelines on thyroid disorders in pregnancy, focusing on hypothyroidism
Tim Korevaar, The Netherlands
13.25 – 13.45 Hypothyroidism in pregnancy
Rima Dhillon-Smith, UK
13.45 – 13.55 Debate and panel discussion with presenters and Chair
13.55 – 14.00 Summary and closing remarks
Nemencio A Nicodemus Jr, Philippines
Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996. His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 60 countries and has published 482 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.
Currently serving as Professor of the Department of Biochemistry and Molecular Biology at the University of the Philippines College of Medicine, and a Clinical Professor at the Division of Endocrinology, Diabetes and Metabolism of the Department of Medicine at the Philippine General Hospital, Dr Nemencio Nicodemus Jr. is also Vice Chair for Postgraduate Training and the departmental training officer. Nationally, Prof. Nicodemus is the Treasurer of the Philippine College of Physicians, President of the Philippine Association for the Study of Overweight and Obesity (PASOO) and a past President of the Philippine Thyroid Association and the Philippine Society of Endocrinology, Diabetes and Metabolism. An active and engaging lecturer, Dr Nicodemus has been invited to several regional and international conferences, including the International Society of Endocrinology, International Diabetes Federation and ASEAN Federation of Endocrine Societies as a resource speaker. Prof. Nicodemus has published several articles and book chapters on diabetes, thyroid and obesity. He is a member of the technical committee who oversee clinical practice guidelines on diabetes in pregnancy and thyroid disorders in pregnancy, including guidelines on recurrent pregnancy loss in the Philippines.
Tim Korevaar is an obstetric internist and endocrinologist at the Erasmus University Medical Center in Rotterdam, the Netherlands. His key research interest is gestational and placental endocrinology including thyroid disease in fertility and pregnancy. Doctor Korevaar is the co-founder and coordinator of the Consortium on Thyroid and Pregnancy, the co-chair of the current ATA guidelines on Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum and co-chair of the European Thyroid Association Guidelines on Hypothyroidism and Thyroid Autoimmunity During Pregnancy. He has been awarded with the Dutch Royal Academy of Sciences Early Career Award and the ESE Young Investigator Award and has published more than 130 peer-reviewed articles.
Stay in the know with our CME updates
